Rapid Dose logo.png
Rapid Dose Therapeutics Signs Exclusive Manufacturing and Distribution Agreement With MapleX Naturals Inc.
April 13, 2021 07:30 ET | Rapid Dose Therapeutics
BURLINGTON, Ontario, April 13, 2021 (GLOBE NEWSWIRE) -- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), is a Canadian Life Science company focused on...
Rapid Dose logo.png
Rapid Dose Therapeutics Announces Grant of Incentive Stock Options and the Issuance of Warrants
March 30, 2021 17:44 ET | Rapid Dose Therapeutics
BURLINGTON, Ontario, March 30, 2021 (GLOBE NEWSWIRE) -- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), announces, pursuant to its Stock Option Plan, the granting of incentive...
Rapid Dose logo.png
Rapid Dose Therapeutics Closes Purchase and Amalgamation of Consolidated Craft Brands
March 19, 2021 17:44 ET | Rapid Dose Therapeutics
BURLINGTON, Ontario, March 19, 2021 (GLOBE NEWSWIRE) -- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), is a Canadian life sciences company focused on innovative drug and active...
Rapid Dose logo.png
Rapid Dose Therapeutics Signs Production Agreement With OG Laboratories to Produce Cannabis Vape and CBD From Hemp Products
March 10, 2021 17:14 ET | Rapid Dose Therapeutics
BURLINGTON, Ontario, March 10, 2021 (GLOBE NEWSWIRE) -- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) is a Canadian Life Science company focused on innovative drug and active...
Rapid Dose logo.png
Rapid Dose Therapeutics Completes Amalgamation of Consolidated Craft Brands
March 08, 2021 09:17 ET | Rapid Dose Therapeutics
BURLINGTON, Ontario, March 08, 2021 (GLOBE NEWSWIRE) -- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), is a Canadian life sciences company focused on innovative drug and active...
Rapid Dose logo.png
Rapid Dose Therapeutics Executes Letter Of Intent To Acquire Consolidated Craft Brands
January 12, 2021 15:19 ET | Rapid Dose Therapeutics
BURLINGTON, Ontario, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active...
Rapid Dose logo.png
Rapid Dose Therapeutics Announces Cease Trade Order Due to Delay in Annual Filings Under COVID-19 Duress
August 20, 2020 14:14 ET | Rapid Dose Therapeutics
BURLINGTON, Ontario, Aug. 20, 2020 (GLOBE NEWSWIRE) -- Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Company”) announces that, due to circumstances beyond its control created by and...
Rapid Dose logo.png
Rapid Dose Therapeutics Announces a New Board Member
August 13, 2020 17:07 ET | Rapid Dose Therapeutics
BURLINGTON, Ontario, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Rapid Dose Therapeutics Corp. trading on the Canadian Securities Exchange (“CSE”) under the symbol DOSE (“RDT” or the “Company”) announces the...
Rapid Dose logo.png
Rapid Dose Therapeutics Announces Credit Facility Financing
August 11, 2020 17:29 ET | Rapid Dose Therapeutics
BURLINGTON, Ontario, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Rapid Dose Therapeutics Corp. trading on the Canadian Securities Exchange (“CSE”) under the symbol DOSE (“RDT” or the “Company”) announces that...
Rapid Dose logo.png
Rapid Dose Therapeutics Announces Delay in Quarterly Filings Under COVID-19 Duress
July 31, 2020 18:02 ET | Rapid Dose Therapeutics
BURLINGTON, Ontario, July 31, 2020 (GLOBE NEWSWIRE) -- Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Company”) announces that due to circumstances created by the COVID-19 pandemic, the...